Investing.com - Carl Zeiss Meditec reported on Friday fourth quarter earnings that matched analysts' forecasts and revenue that fell short of expectations.
Carl Zeiss Meditec announced earnings per share of €0.7 on revenue of €477.4M. Analysts polled by Investing.com anticipated EPS of €0.7 on revenue of €477.42M.
Carl Zeiss Meditec shares are down 31% from the beginning of the year, still down 37.28% from its 52 week high of €202.00 set on September 17, 2021. They are under-performing the STOXX 600 which is down 13.83% from the start of the year.
Carl Zeiss Meditec follows other major Healthcare sector earnings this month
Carl Zeiss Meditec's report follows an earnings beat by Merck on Friday, who reported EPS of €2.64 on revenue of €5.57B, compared to forecasts EPS of €2.51 on revenue of €5.42B.
Carl Zeiss AG had matched expectations on Friday with fourth quarter EPS of €0.7 on revenue of €477.4M, compared to forecast for EPS of €0.7 on revenue of €477.42M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar